EMJ GOLD - European Medical Journal

Continue

Pharma News, Views & Analysis

Filter Advertise With Us
Illustration of man administering vaccine to a woman

GSK pursues co-administration of RSV and shingles vaccines

This summer, GSK revised its annual vaccine sales forecast after new guidance on RSV from the CDC. However, new findings on the co-administration of this and its existing shingles vaccine offers new hope.

Musk's vision implant gets FDA breakthrough device tag

Neuralink, Elon Musk’s brain-chip startup, has been given breakthrough device designation from the FDA for its experimental implant aimed at restoring vision.

Warner Biddle takes top job at Kyverna Therapeutics

Warner Biddle has been appointed as CEO, Kyverna Therapeutics, following the resignation of Peter Maag this week.
Illustration of a horizontal vaccine

Roche's twice-yearly MS injection wins FDA approval

The FDA has approved Roche’s subcutaneous injection for relapsing multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS).

Company reputation key to HCP prescribing decisions

New research shows that healthcare professionals consider a company’s leadership in a specific disease area and its overall reputation to be influential in prescribing decisions.

FDA lifts partial clinical hold on Rezolute hyperinsulinism treatment

The lift is based on new research showing that the previous adverse effects in laboratory rats may not have been caused by the drug itself.

New AI-focused RNA collaboration for Eli Lilly

Eli Lilly has entered into a research collaboration with Genetic Leap, a private company focused on AI, to advance the development of RNA-based genetic medicines.  

NICE endorses Novartis’ take home drug for rare blood disorder

NICE recommends an oral therapy for adults with PNH, marking the 1000th medicine evaluated since its inception in 1999.